Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
Collections open for submissions
- Latest updates from major conferences
- First-ever clinical trials
- New developments in delivery technology, materials, and molecular engineering for drug discovery
Latest updates from major conferences
This Journal of Hematology & Oncology and Experimental Hematology & Oncology series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference.
First-ever clinical trials
This series calls for clinical studies on novel agents for cancers and blood disorders. Summaries and reviews on first-in-human or first-in-class studies are also welcome.
weyo / stock.adobe.com
New developments in delivery technology, materials, and molecular engineering for drug discovery
This series covers new technology, materials, and models for drug discovery. Development and applications of organoids, 3D cultures, PDX modes, nano-molecules, AI technology, and single-cell maps for drug discovery will be the focus.
Aims and scope
Articles
-
-
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
-
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
-
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL
-
Genitourinary cancers updates: highlights from ASCO 2023
-
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
-
The effects of β-glucan on human immune and cancer cells
-
The diagnosis and management of NK/T-cell lymphomas
-
NK cell-based cancer immunotherapy: from basic biology to clinical development
-
Mechanism of action of lenalidomide in hematological malignancies
Blood Cancer Awareness Month
In recognition of Blood Cancer Awareness Month, this September, Editors from across our hybrid and OA oncology journals have chosen a compilation of articles to highlight the latest advances in blood cancer research.
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology.
CAHON: Stop hate crimes and racism
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
Editor's quote
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
-
Official journal of
-
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Instructions for authors
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
28.5 - 2-year Impact Factor
23.1 - 5-year Impact Factor
4.045 - SNIP (Source Normalized Impact per Paper)
6.046 - SJR (SCImago Journal Rank)2022 Speed
5 days submission to first editorial decision for all manuscripts (Median)
74 days submission to accept (Median)2022 Usage
2,836,875 downloads
9,883 Altmetric mentions
On the blog
-
Winners of the 2022 Cardio-Oncology Journal Prize
06 April 2023
-
-
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).